Citation:
朱精强,汪洵理,魏涛,黄秋实,李志辉,龚日祥,龚艳萍,文乐斌,朱信心,马宇,刘枫,邹秀和,杜镇鸿,陈强,孙映荷,陈海. Application of Lymphatic Mapping to Recognize and Protect Negative Stained Parathyroid in Thyroid Carcinoma Surgery by Using Carbon Nanoparticles. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2013, 20(9): 992-994. doi: 10.7507/1007-9424.20130250
Copy
1. |
Yang F, Jin C, Yang D, et al. Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment[J]. Eur J Cancer, 2011, 47(12):1873-1882.
|
2. |
Khairy GA, Al-Saif A. Incidental parathyroidectomy during thyroidresection:incidence, risk factors, and outcome[J]. Ann Saudi Med, 2011, 31(3):274-278.
|
3. |
Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer:comparison of complicationand recurrence rates in 295 initial dissections and reoperations[J]. Arch Surg, 2010, 145(3):272-275.
|
4. |
Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillarythyroid carcinoma[J]. World J Surg, 2010, 34(6):1187-1191.
|
5. |
Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphos-cintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study[J]. J Surg Oncol, 2001, 77(1):21-24.
|
6. |
Haigh PI, Giuliano AE. Sentinel lymph node dissection for thyroidmalignancy[J]. Recent Results Cancer Res, 2000, 157(12):201-205.
|
7. |
Ji YB, Lee KJ, Park YS, et al. Clinical efficacy of sentinel lymphnode biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma[J]. Ann Surg Oncol, 2012, 19(6):1868-1873.
|
- 1. Yang F, Jin C, Yang D, et al. Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment[J]. Eur J Cancer, 2011, 47(12):1873-1882.
- 2. Khairy GA, Al-Saif A. Incidental parathyroidectomy during thyroidresection:incidence, risk factors, and outcome[J]. Ann Saudi Med, 2011, 31(3):274-278.
- 3. Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer:comparison of complicationand recurrence rates in 295 initial dissections and reoperations[J]. Arch Surg, 2010, 145(3):272-275.
- 4. Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillarythyroid carcinoma[J]. World J Surg, 2010, 34(6):1187-1191.
- 5. Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphos-cintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study[J]. J Surg Oncol, 2001, 77(1):21-24.
- 6. Haigh PI, Giuliano AE. Sentinel lymph node dissection for thyroidmalignancy[J]. Recent Results Cancer Res, 2000, 157(12):201-205.
- 7. Ji YB, Lee KJ, Park YS, et al. Clinical efficacy of sentinel lymphnode biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma[J]. Ann Surg Oncol, 2012, 19(6):1868-1873.